Do pharmaceutical companies suppress inexpensive universal cures because chronic treatment is more profitable?
Drug pricing, conflicts of interest and commercial incentives are real issues, but they do not establish that a known universal cure exists and is being suppressed. Cancer and other major diseases are biologically heterogeneous, and publicly funded research programs openly test treatments that are not dependent on a single company's business model.